Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma

Docetaxel is a commonly used chemotherapeutic agent in a variety of cancer treatment regimens. We present a case of apparent docetaxel-induced Stevens-Johnson syndrome (SJS) in a patient recently treated for metastatic prostate cancer. This medication is not classically associated with the developme...

Descripción completa

Detalles Bibliográficos
Autores principales: Diab, Osama, Mcentire, Dan, Kassim, Thamer, Nayfeh, Ali, Dajani, Abdel Rahman, Kerfeld, Mitchell, Campbell, Jonathon, Alsuwaidan, Adbullah, Hazeem, Mahmoud Abu, Gbadamosi-Akindele, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341237/
https://www.ncbi.nlm.nih.gov/pubmed/30729055
http://dx.doi.org/10.1155/2019/7928752
_version_ 1783388921366839296
author Diab, Osama
Mcentire, Dan
Kassim, Thamer
Nayfeh, Ali
Dajani, Abdel Rahman
Kerfeld, Mitchell
Campbell, Jonathon
Alsuwaidan, Adbullah
Hazeem, Mahmoud Abu
Gbadamosi-Akindele, Maryam
author_facet Diab, Osama
Mcentire, Dan
Kassim, Thamer
Nayfeh, Ali
Dajani, Abdel Rahman
Kerfeld, Mitchell
Campbell, Jonathon
Alsuwaidan, Adbullah
Hazeem, Mahmoud Abu
Gbadamosi-Akindele, Maryam
author_sort Diab, Osama
collection PubMed
description Docetaxel is a commonly used chemotherapeutic agent in a variety of cancer treatment regimens. We present a case of apparent docetaxel-induced Stevens-Johnson syndrome (SJS) in a patient recently treated for metastatic prostate cancer. This medication is not classically associated with the development of SJS but in our case, along with a number of other case reports, and a single phase II clinical trial, an association was recognized. We encourage clinicians who employ the use of this medication to be aware of this relationship.
format Online
Article
Text
id pubmed-6341237
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63412372019-02-06 Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma Diab, Osama Mcentire, Dan Kassim, Thamer Nayfeh, Ali Dajani, Abdel Rahman Kerfeld, Mitchell Campbell, Jonathon Alsuwaidan, Adbullah Hazeem, Mahmoud Abu Gbadamosi-Akindele, Maryam Case Rep Oncol Med Case Report Docetaxel is a commonly used chemotherapeutic agent in a variety of cancer treatment regimens. We present a case of apparent docetaxel-induced Stevens-Johnson syndrome (SJS) in a patient recently treated for metastatic prostate cancer. This medication is not classically associated with the development of SJS but in our case, along with a number of other case reports, and a single phase II clinical trial, an association was recognized. We encourage clinicians who employ the use of this medication to be aware of this relationship. Hindawi 2019-01-08 /pmc/articles/PMC6341237/ /pubmed/30729055 http://dx.doi.org/10.1155/2019/7928752 Text en Copyright © 2019 Osama Diab et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Diab, Osama
Mcentire, Dan
Kassim, Thamer
Nayfeh, Ali
Dajani, Abdel Rahman
Kerfeld, Mitchell
Campbell, Jonathon
Alsuwaidan, Adbullah
Hazeem, Mahmoud Abu
Gbadamosi-Akindele, Maryam
Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma
title Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma
title_full Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma
title_fullStr Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma
title_full_unstemmed Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma
title_short Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma
title_sort docetaxel-induced stevens-johnson syndrome in a patient with metastatic prostate adenocarcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341237/
https://www.ncbi.nlm.nih.gov/pubmed/30729055
http://dx.doi.org/10.1155/2019/7928752
work_keys_str_mv AT diabosama docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma
AT mcentiredan docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma
AT kassimthamer docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma
AT nayfehali docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma
AT dajaniabdelrahman docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma
AT kerfeldmitchell docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma
AT campbelljonathon docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma
AT alsuwaidanadbullah docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma
AT hazeemmahmoudabu docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma
AT gbadamosiakindelemaryam docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma

Ejemplares similares